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Abstract 18	
Cellular activation in trans by interferons, cytokines and chemokines is a commonly 19	
recognized mechanism to amplify immune effector function and limit pathogen 20	
spread.  However, an optimal host response also requires that collateral damage 21	
associated with inflammation is limited.   This may be particularly so in the case of 22	
granulomatous inflammation, where an excessive number and / or excessively florid 23	
granulomas can have significant pathological consequences.  Here, we have combined 24	
transcriptomics, agent-based modeling and in vivo experimental approaches to study 25	
constraints on hepatic granuloma formation in a murine model of experimental 26	
leishmaniasis.  We demonstrate that chemokine production by non-infected Kupffer 27	
cells in the Leishmania donovani-infected liver promotes competition with infected 28	
KCs for available iNKT cells, ultimately inhibiting the extent of granulomatous 29	
inflammation.   We propose trans-activation for chemokine production as a novel 30	
broadly applicable mechanism that may operate early in infection to limit excessive 31	
focal inflammation.   32	
 33	
  34	
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Introduction 35	
Immune responses are commonly initiated by localized infectious insult and multiple 36	
mechanisms have evolved to allow spread of host effector responses to meet the 37	
challenge of pathogen containment.  In the late 1950Õs, seminal studies by Isaacs and 38	
Lindenmann defined how ÒinterferonsÕ amplified local cellular resistance following 39	
virus infection [1, 2].   A decade later, Mackaness described cross protective cellular 40	
immunity mediated via T cell cytokine-dependent macrophage activation [3].  More 41	
recently, cytokine-and chemokine- mediated amplification of host protective 42	
immunity has been described across a spectrum of responses driven by both innate 43	
lymphoid cells and via conventional T cells [4-9]. Whilst serving to eliminate 44	
pathogens more effectively, a potentially undesirable consequence of amplifying 45	
immune effector responses is immunopathology, collateral damage induced by an 46	
over-zealous drive towards inflammation.  Hence, an equally impressive array of 47	
ÒregulatoryÓ or ÒsuppressiveÓ mechanisms have been defined that serve to limit 48	
immunopathology, and that suggest an evolutionary balance between pathogen 49	
elimination and host survival [10-12].   50	
 51	
Granulomatous inflammation represents an extreme form of focal inflammation, often 52	
initiated around pathogens or foreign bodies that pose a formidable challenge for 53	
immune clearance.  Granulomas are a hallmark of the immunopathology of many 54	
human infectious diseases including tuberculosis [13, 14], schistosomiasis [15]and 55	
leishmaniasis [16].   Whilst granuloma formation may provide means for containment 56	
and be host beneficial, excessive granuloma formation, numerically or in terms of 57	
individual granuloma size can lead to severe pathological consequences.   Hence, 58	
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mechanisms for limiting the exuberance of the granulomatous response through late 59	
acting regulatory pathways are also well described in the literature [17-20].  However, 60	
the question of whether additional regulatory mechanisms operate at the earliest 61	
stages of granuloma initiation and prevent or limit over-exuberant granuloma 62	
formation has not been previously addressed.   63	
 64	
Experimental visceral leishmaniasis, resulting from infection of mice with the Kupffer 65	
cell (KC) tropic parasite Leishmania donovani, has provided a highly tractable tool to 66	
study the initiation of granulomatous pathology in the hepatic microenvironment.  67	
Following infection of mice with L. donovani, infected KCs transiently release the 68	
chemokines CCL1, CCL2 and CXCL10 in a T cell-independent manner, whereas 69	
sustained expression of CXCL10 is dependent upon IFNγ production by invariant 70	
NKT (iNKT) cells [21].  IFNγ production by iNKT cells is in turn costimulated by 71	
ligation of CD47 on NKT cells by signal regulatory protein alpha (SIRPα) expressed 72	
on KCs, providing positive feedback for sustained iNKT cell recruitment and KC 73	
activation [22].   A similar role for CXC chemokines in recruiting hepatic NKT cells 74	
has been observed in other models of liver infection / inflammation [23, 24]. For 75	
example, CXCL9 produced by KCs following infection with the bacterium Borrelia 76	
burgdorferi results in CXCR3-dependent clustering of NKT cells around infected 77	
KCs [25] whereas CXCR6 and its ligand CXCL16 regulate NKT cell accumulation in 78	
the liver during fibrosis [26].  Hence, early recruitment of ÒamplifierÓ cells such as 79	
NKT cells is a central and common theme of focal inflammation.  80	
 81	
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Examination of the kinetics of granulomatous inflammation in this model of visceral 82	
leishmaniasis suggests, however, that there may be inherent limitations imposed on 83	
the ability of the host to form hepatic granulomas.  Notably, granuloma formation 84	
proceeds asynchronously, and even many weeks after infection, fully formed 85	
granulomas sit side by side with infected KCs that appear to have failed to stimulate 86	
an inflammatory focus [16, 27].   Here, we have combined transcriptional profiling 87	
and computational modeling to probe possible mechanisms that might underpin the 88	
asynchronous development of granulomas in this model.  We demonstrate that KC 89	
chemokine production, contrary to expectations, is not restricted to infected cells 90	
alone, but spreads in trans to include uninfected KCs within the infected liver.  Data 91	
generated using a novel agent based model (ABM) in which KCs and iNKT cells 92	
interact within a spatially constrained sinusoidal network suggest that the spreading of 93	
chemokine production to uninfected KCs limits the competitiveness of infected KCs 94	
in terms of their ability to attract iNKT cells and initiate granuloma formation.  In 95	
silico experiments predicted that this competition could be overcome by increasing 96	
the number of available NKT cells, a prediction borne out in vivo.  Hence, our data 97	
identify a new pathway that operates early in infection to limit excessive 98	
inflammation by introducing competition for a finite resource (i.e. iNKT cells) that is 99	
needed for granuloma initiation. 100	
 101	
Materials and Methods 102	
Mice and parasites.  103	
C57BL6 mice were obtained from Charles River (UK). mT/mG [28] and LysMcre 104	
[29] mice have been previously described. Mice were bred and housed under specific 105	
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pathogen-free conditions and used at 6-12 weeks of age. The tandom Tomato 106	
fluorescent protein expressing Ethiopian strain of Leishmania donovani (tdTom.LV9) 107	
[30] were maintained by serial passage in Rag1
-/- mice. Amastigotes were isolated 108	
from infected spleens, and mice were infected with 3x10
7 L. donovani amastigotes 109	
intravenously (i.v.) via the tail vein in 200μl of RPMI 1640 (GIBCO, UK).  All 110	
animal procedures were approved by the University of York Animal Welfare and 111	
Ethical Review Board and carried out in accordance with UK Home Office license 112	
(PPL 60/4377). 113	
 114	
Microarray analysis 115	
As previously described [31], Kupffer cells were flow sorted (on the basis of 116	
SSC/FSC and expression of CRIg, Gr-1 and F4/80) from naive mice and from 117	
infected mice and KCs from infected mice were further sorted (on the basis of 118	
TdTomato expression) into those containing amastigotes (ÒinfectedÓ) and those that 119	
did not (ÒinflamedÓ). A total of 64 mice were used in the microarry study, in four 120	
independent infection experiments.  RNA was isolated, amplified and equal amounts 121	
were assayed using Agilent SurePrint G3 Gene Expression 8x60 Microarray chips.  122	
Scanned data were normalized (80
th
 percentile) and gene expression data analysed 123	
using Genespring v9.  Differentially expressed (DE) genes were defined using a false 124	
discovery rate (FDR) of 5%.  Source data is accessible from EBI Array Express (E-125	
MEXP-3877) and methodology for subsequent data analysis is described in further 126	
detail elsewhere [31]. 127	
 128	
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Histological Analysis.  129	
Mice were treated with 1µg recombinant IL-15 (BioLegend) intravenously and 130	
infected 3 days later. Four days post-infection, mice livers were extracted, weighed 131	
then placed into 2% PFA in PBS for 2 hours, then 30% sucrose in PBS overnight. 132	
Tissues were then embedded in Optimal Cutting Temperature (OCT)(Sakura) and 133	
stored at -70¡C until use. 10µm cryosections were fixed and labeled with Alexa647 or 134	
Alexa488 conjugated F4/80 (eBioscience) and DAPI (Invitrogen) to visualize KCs 135	
and cell nuclei respectively. Images were captured as 0.81µm optical slices using a 136	
LSM510 confocal microscope (Zeiss). Blinded slides were imaged to score the 137	
percentage of infected foci having formed a distinct inflammatory focus (greater than 138	
15 cells), with imaging fields selected via tdTomato expression. 139	
 140	
Flow Cytometry.  141	
Livers were homogenized and mononuclear cells prepared as previously described 142	
[30]. Cells were incubated with anti-CD16/32 and then labeled with NK1.1, CD3, 143	
B220 and CD1d tetramer (a kind gift from V. Cerundulo) to identify T, NK and NKT 144	
cells. Samples were analyzed using a CyAn flow cytometer with Summit software 145	
(DAKO). Autofluorescent events and dead cells were excluded from analysis by 146	
gating on unused fluorescent channels and LIVE/DEAD fixable dead cell stain 147	
(Invitrogen) respectively. 148	
 149	
Parameterizing and Calibrating the Simulation.  150	
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A full summary of the biological data available that was used to calibrate the 151	
simulation is listed in Table S1.  The entire list of baseline simulation parameters is 152	
found in Tables S3.  Full details of parameterization and calibration of the simulation 153	
are provided in the Supplemental Experimental Procedures.  154	
 155	
Statistical Analysis.  156	
When quantifying granulomas, experimental data are expressed as mean ± SEM for 157	
each group of 5 mice from two independent experiments, and statistical analyses 158	
performed using two-tailed paired Student t-tests. All tests used 95% confidence 159	
intervals. Simulation data non-normality was determined using the DÕAgostino and 160	
Pearson test, and non-normal simulation data was analyzed using either Wilcoxon 161	
signed-rank or Kolmogorov-Smirnov tests where appropriate. Aleatory analysis was 162	
used to determine the minimum number of simulation results required to mitigate 163	
stochastic uncertainty (see Figure S4). Latin-hypercube sensitivity analysis was 164	
facilitated by using the Spartan tool for understanding uncertainty in simulations [32]. 165	
 166	
Results 167	
Chemokine production by KCs in mice infected with L. donovani 168	
Both chemokines and iNKT cells are central to the initiation of granulomatous 169	
inflammation following L. donovani infection.  In order to gain insight into the 170	
production of chemokines involved in KC-directed recruitment of NKT cells, we used 171	
transcriptional profiling of KCs isolated from mice infected with L. donovani as 172	
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previously described [31].  Following infection of mice with Td-tomato transgenic L. 173	
donovani, approx. 20% of the KC population are infected with amastigotes.  We 174	
isolated KCs from infected mice and sort purified these KCs on the basis of whether 175	
they contained intracellular amastigotes (ÒinfectedÕ) or not (herein referred to as 176	
ÒinflamedÓ to denote their exposure to inflammatory signals in vivo) [31].  As shown 177	
in Figure 1A, KCs from infected mice expressed a variety of chemokines when 178	
compared to KCs isolated from nave mice.  At 2h post infection (p.i.), enhanced 179	
accumulation of mRNAs for Cxcl1, Cxcl2, Cxcl3 and Cxcl5, as well as Ccl3 and Ccl4, 180	
was evident (determined as differentially expressed using a 5% FDR).  This 181	
transcriptional response was transient, in keeping with previous studies at the level of 182	
whole liver tissue [21].  Rapid secretion of chemokines in response to L. donovani 183	
infection can also be inferred from studies in which G-protein coupled receptor 184	
signaling was abrogated by pertussis toxin [22].  A suite of inducible chemokines, 185	
including Cxcl9, Cxcl10, Ccl8 and Ccl12 showed enhanced mRNA accumulation at 186	
12h p.i. (at a 5% FDR), again in keeping with data in whole liver and with previously 187	
published data indicating the production of IFNg by iNKT cells during early L. 188	
donovani infection (e.g. Figure 2 in reference 22).  For example, qRT-PCR 189	
demonstrated sustained and elevated Cxcl10 at 24h p.i. [33].  Similarly, 190	
transcriptional profiling of the livers of infected BALB/c mice (n=4-5 per time point) 191	
indicates sustained elevation of Cxcl9 (Log2FC compared to controls of 5.25, 5.14, 192	
5.34 and 4.74 for days 15, 21, 36 and 42 p.i. respectively; FDR 0.05, p<0.05) and 193	
Cxcl10 (Log2FC of 4.84, 4.92, 5.36 and 4.55, respectively; Ashwin et al, manuscript 194	
in preparation).   Strikingly, there was little difference to discriminate the chemokine 195	
response of infected vs. inflamed KCs, although we cannot rule out different degrees 196	
of post transcriptional regulation of chemokine secretion in infected vs. inflamed KCs 197	
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[34].  Collectively, our data suggest that although initiated by infection, production of 198	
chemokines rapidly spreads in trans throughout the liver KC network.  199	
 200	
Chemokine induction by infected cells is thought to provide a means for focal 201	
inflammation, the recruitment of additional leucocytes in an ordered manner being 202	
essential for granuloma formation and the ultimate activation of macrophage host 203	
defense mechanisms.  However, given this argument, these data appear 204	
counterintuitive.  In order to try to understand how transactivation for chemokine 205	
production might influence the generation of focal inflammation, and given the 206	
absence of tools to selectively and directly manipulate chemokine production by 207	
infected vs. uninfected KCs in vivo, we adopted an in silico experimental approach 208	
conducive to testing a variety of different hypotheses (Figure 1B and C).   209	
 210	
An agent-based model of the hepatic sinusoidal microenvironment.  211	
Agent based models, where rule-driven ÒagentsÓ can represent a cell or lower-scale 212	
entities of interest, are naturally suited to simulating inflammation in a spatially 213	
constrained environment [35-37]. To construct this environment, we used published 214	
3D data describing the overall size of lobules, the average non-branched sinusoid 215	
length, and the branching angles between sinusoids [38] as the basis for developing a 216	
novel algorithm to generate statistically realistic liver lobule sections similar to that 217	
reported recently [39].  A range of quasi-2D sinusoidal network structures, where 218	
each structure can be considered as a slice through a 3D lobule,  was created using a 219	
multi-stage generative algorithm augmented with these data [38] (Figure 2A, Movie 220	
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S1, Figure S1A-D and Table S1 and Supplementary Experimental Procedures). 221	
The resulting networks (Figure 2B), represented as graphs of nodes connected by 222	
edges, serve as discrete spatial simulation environments that mimic the sinusoidal 223	
structure observed in live mice imaged by 2-photon intra-vital microscopy in (mT/mG 224	
x lysMcre)F1, as previously described [30] (Figure 2A vs. 2C). Analysis (by Pearson 225	
correlation coefficients and Kolmogorov-Smirnov tests) using 10 independently 226	
generated structures indicated that variance in structure per se had minimal impact on 227	
the results of subsequent simulations (see below). 228	
 229	
We defined where and how cellular interactions were allowed to occur within our 230	
simulation environment based on 3 different types of network node: periportal nodes, 231	
located at the peripheries of the structure allow NKT cells to enter and exit the 232	
simulated lobule section; regular-nodes, capable of holding a single KC and any 233	
number of NKT cells; and a single centrilobular-node, representing the central vein 234	
where NKT cells could exit the structure. Only NKT cells were capable of movement 235	
within the structure. KCs remain immobile, as reported in early stages of infection 236	
with B. bugdorferi [25], BCG [40] and L. donovani [30].  Our KC placement 237	
algorithm distributes KCs in periportal, midzonal and centrilobular locations in a ratio 238	
of 4:3:3, based on [41, 42]. As centrilobular KCs have reduced phagocytic capability 239	
compared to periportal KCs [41], the distribution of infected KCs in our simulation is 240	
65% periportal, 25% midzonal and 10% centrilobular for the purposes of 241	
experimentation. 242	
 243	
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A detailed description of the model and key assumptions is provided in the 244	
Supplemental Experimental Procedures and Tables S2 and S3.  State diagrams 245	
written in the Unified Modeling Language that illustrate the behaviour associated with 246	
KCs and NKT cells are provided in Figure S2.  Briefly, mechanisms of cellular 247	
attraction and retention were modeled generically, since the precise function, 248	
functional overlap, and interaction between distinct chemokines has yet to be fully 249	
elucidated. For the purposes of the current abstraction, we refer to the chemokines as 250	
attractive and retentive, being independent and quantitatively distinct and with 251	
discrete areas of influence. The simulation was constructed to allow both a minimum 252	
and a maximum diffusion distance to be parameterized for all chemo-attractants 253	
produced by KCs. NKT cells traverse the sinusoidal network at 10-20µm/min with a 254	
random walk behavior [25], with no enforcement of directionality unless under the 255	
attractive influence of KC-derived chemokines. Strength of attraction is modeled as a 256	
function of distance from the source KC.  Upon interaction with infected KCs, NKT 257	
cells produce IFNγ (as a representation of all macrophage-activating cytokines) 258	
following cognate receptor engagement [22], facilitating KC activation and NKT cell 259	
arrest [25, 43].  Our previous data on SIRPα-CD47 has suggested that cognate 260	
receptor-ligand interactions also regulate NKT cell retention on infected KCs, with 261	
the induced expression of SIRPα after infection being preferentially but not 262	
exclusively observed on infected KCs [22]. In our model, this interaction is used to 263	
represent a cognate retention signal, but this reflects an abstraction of what may be 264	
potentially much more complex interactions. The amplification of KC derived 265	
attractive chemokines through this process can lead to the accumulation of multiple 266	
NKT cells at a given KC (referred to here as Òinflammatory fociÓ). It is assumed that 267	
through the sum of all KC-NKT cell interactions within an inflammatory focus, a 268	
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threshold for granuloma formation and the subsequent recruitment of additional 269	
leucocytes associated with maturing granulomas (including B cells, T cells, 270	
monocytes and NK cells) is reached, but these cells and processes are not explicitly 271	
modeled.  We have also not modeled the ultimate microbicidal activity of these 272	
granulomas.   273	
 274	
Parasite Induced Activation of Infected KCs with/without Bystander Chemokine 275	
production by Uninfected KCs.  276	
Two experimental scenarios were devised to investigate the influence of varying both 277	
infected and inflamed KC function. Scenario 1 (Figure 1B) was constructed to restrict 278	
chemokine production to infected KCs only, and scenario 2 (Figure 1C) to 279	
investigate the impact of transactivation of KC for chemokine production.  As KC 280	
activation of NKT cells is optimal in the presence of cognate interactions [22], our 281	
model assumes these are a requirement for retention;  hence only infected KCs can 282	
generate stable inflammatory foci, and these foci, for the purposes of the model, are 283	
composed only of NKT cells and KCs.   In contrast, inflamed KCs in scenario 2 might 284	
act as potential competitors for available NKT cells, being able to attract but not 285	
retain them.   Although this model can be used to probe a variety of different potential 286	
questions related to the initiation of granuloma formation (see Discussion), we focus 287	
here on a factorial analysis that involved simultaneously modifying the simulation 288	
parameters related to chemokine diffusion distance, time required to activate KCs, 289	
and time for KCs to reach maximal chemokine production.  290	
 291	
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Firstly, we quantified the influence of distance from effect on attraction. Factorial 292	
analysis, modifying the maximum diffusion distance of chemokine, showed that 293	
greater chemokine diffusion distance leads to increased percentages of infected KCs 294	
forming inflammatory foci in both scenarios (Figure 1B and C), whether those foci 295	
were qualified as containing 4, 6 or 8 NKT cells. However, our simulation predicted 296	
diminishing returns when increasing maximum diffusion past ~120µm (Figure S1E).  297	
Thus, significant differences (P=≤0.001) were observed when comparing the 298	
frequency of inflammatory foci that resulted from each increase in diffusion distance 299	
against the previous distance (e.g. 20µm-30µm: P=0.001216, 30µm-40µm: 300	
P=0.000019).  However, when increasing from 120µm-130µm and beyond, the 301	
increase in inflammatory foci was not significant (P=0.312). Interestingly, this tipping 302	
point is close to the ∼100µm reported as the distance of a functional chemokine 303	
gradient in vivo [44].  These results suggest that if it were possible to selectively 304	
increase chemokine diffusion via increased production (or other means) by infected 305	
KCs compared to inflamed KCs, or conversely decrease chemokine diffusion by 306	
inflamed KCs, infected KCs would gain competitive advantage in terms of attracting 307	
NKT cells.  308	
 309	
We next compared our two experimental scenarios in terms of total stimulation time 310	
(i.e. a measure of activation) received by the entire infected KC population, and the 311	
frequency of inflammatory foci formed associated with that population. Figure 3A 312	
illustrates a response curve for scenario 1 showing the total stimulation time received 313	
by all infected KCs, across a range of the two main parameters that determine KC 314	
activation dynamics Ð the time required to activate KCs and the duration KCs remain 315	
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activated. When comparing this response landscape of scenario 1 with that generated 316	
in scenario 2 (Figure 3C), there was a marked reduction in stimulation time received 317	
overall by infected KCs in scenario 2 compared to scenario 1.  This trend is also 318	
observable when comparing the percentage of inflammatory foci, whether qualified at 319	
8 NKT cells (Figure 3B for scenario 1 and Figure 3D for scenario 2) or at 4 or 6 320	
NKT cells (data not shown).   321	
 322	
Together, these results demonstrate that in comparison to chemokine production 323	
restricted to infected KCs, additional chemokine production by inflamed KC 324	
generates a less focused inflammatory response, measured either by frequency of 325	
infected KC that form inflammatory foci, or by stimulation time received by infected 326	
KCs.  This result most likely reflects the liver lobule becoming saturated with 327	
attractive chemokines derived from both inflamed and infected KCs in scenario 2, 328	
reducing the competitiveness of infected KCs to selectively recruit NKT cells.  In 329	
other words, chemokine production by inflamed KC acts in a negative immune 330	
regulatory manner, limiting the extent of the inflammatory response around infected 331	
KCs. 332	
 333	
Increasing NKT Cell Numbers Overcomes Bystander Regulation. 334	
We then investigated how modifying the target of this competition affected the 335	
quantity and quality of inflammatory foci generated.  We hypothesized that altering 336	
NKT cell frequency might result in either i) similarly abundant foci, but with each 337	
being more substantive in terms of NKT cellularity, or ii) increased numbers of 338	
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inflammatory foci, thus overcoming the competitive effect of bystander chemokine 339	
production by inflamed KCs (Figure 4A).  Our simulation results showed that 340	
increasing NKT cell numbers above the calibrated value lead to significant increases 341	
in the frequency of inflammatory foci in scenario 1, a result that would be expected.  342	
Strikingly, an increase in frequency of inflammatory foci was also observed to be the 343	
case for scenario 2, regardless of how we qualified focus size (Figure 4B).  For 344	
example, with an increase in NKT cell availability of 2-fold, the number of 345	
inflammatory foci increased 1.5-fold, whereas increasing NKT cells by 3-fold 346	
doubled the frequency of inflammatory foci.   347	
 348	
To test whether this predictive in silico data was also borne out in vivo, we treated 349	
mice for 3 days with recombinant IL-15 to induce increased NKT cell proliferation 350	
and survival [45] and then infected these mice with L. donovani and scored early 351	
granuloma formation.   In uninfected mice, IL-15 treatment resulted in increased 352	
numbers of NKT cells (including CD1d restricted NKT cells), NK cells, and T cells 353	
(Figure 4C-E and Figure S3A-D). In infected mice, all cell types were already 354	
increased in number compared to nave mice, and the effect of IL-15 pre-treatment 355	
was limited to an increase in the number of NKT cells (Figure 4C).  Similarly, IL-15 356	
pre-treatment had no effect on the relative frequency of NK cells and T cells (Figure 357	
S3B-C) but resulted in an increase in the relative frequency of NKT cells (from 15.0 358	
± 0.1% to 17.36 ± 0.8%; n=10; P=0.0043; Figure S3E). 359	
 360	
To ensure that we were scoring a biologically relevant histopathological response, 361	
whilst minimizing potential longer terms effects of rIL-15 treatment, we chose to 362	
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score the granulomas early in their development (day 4 p.i.) and define these as 363	
accumulations of 15 or more cells formed around an infected KC (not discriminating 364	
between NKT cells or other mononuclear cells).  Although there was significant 365	
heterogeneity in size of these granulomas (Figure 4G-H), we found that the 366	
frequency of infected KCs that formed distinct granulomas was increased ∼1.5 fold in 367	
mice pre-treated with IL-15 and which had a higher number of NKT cells in the liver 368	
at the time of infection (P=0.0038; Figure 4F). Thus, treatment of mice with rIL-15, 369	
even under conditions where the increase in NKT cell number is relatively modest, 370	
leads to a significant enhancement in the frequency of infected KCs that can provide a 371	
nidus for granuloma formation.  372	
 373	
Discussion 374	
Granulomas represent a specialized form of inflammation that allows for the focal 375	
delivery of host effector responses and / or containment of pathogen products.   376	
Whilst generally considered host beneficial, excessive granuloma formation may have 377	
significant pathological consequences.   Here, we provide evidence that chemokine-378	
dependent competition between infected and uninfected KCs for iNKT cells in the 379	
hepatic microenvironment acts as a natural attenuator of granuloma formation. 380	
 381	
In models of experimental visceral leishmaniasis, granuloma formation is 382	
asynchronous, limiting the extent of hepatic inflammation, but also delaying parasite 383	
clearance [16, 27].  A variety of different models could explain why isolated infected 384	
KCs can be found at times when other infected KCs are engaged in a fully mature 385	
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granulomatous response.  In a model of Mycobacterium marinarum-induced 386	
granulomas in zebrafish, macrophage migration out of the granuloma has been 387	
observed [14, 46], and it is possible that infected KCs leave granulomas in mice 388	
infected with L. donovani.  However, in both L. donovani-induced granulomas [30] 389	
and BCG-induced granulomas [40, 47] in immunocompetent mice, KCs appear to 390	
retain their characteristic lack of motility.  Alternatively, there may be heterogeneity 391	
in KCs, a subset being more efficient in promoting granulomatous inflammation.  392	
Although we had previously modeled this possibility using an early version of our 393	
ABM [48], our recent studies evaluating differences between yolk-sac derived and 394	
bone marrow-derived KC indicate that both are competent to form granulomas and 395	
participate effectively in this response [49].  A further possibility is that granuloma 396	
formation is rate limited by the availability of key amplifier cells.  Experimental data 397	
to date indicates that iNKT cells play this role in experimental visceral leishmaniasis 398	
[22, 33, 50, 51], though we do not discount a role for other more recently identified 399	
innate lymphoid cells [52, 53].   400	
 401	
Through transcriptional profiling, we demonstrated that both inflamed and infected 402	
KCs produce a variety of inducible chemokines able to attract NKT cells, suggesting 403	
the possibility that uninfected as well as infected KCs could compete for this 404	
resource.  However, as neither the mechanisms that regulate this transactivation nor 405	
experimental means to selectively regulate chemokine production by KCs are 406	
currently available, we adopted a computational approach to further explore this 407	
hypothesis.   ABMs are well-suited towards studying tissue and cellular level 408	
inflammation [35-37]. In constructing our ABM, we developed a novel algorithm for 409	
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creating virtual sinusoidal networks that are visually representative of liver lobule 410	
sections, being defined by published statistics that captured the length between central 411	
vein and portal triad, average lengths of non-branched sinusoids and sinusoid  branch 412	
angles [38]. This represents an improvement on similar work [39]. Our algorithm was 413	
not intended to produce a fully realistic whole lobule structure, but rather we were 414	
interested only in developing suitable quasi-2D vascular networks within liver lobules 415	
to provide an environment for the cellular and chemokine ÒagentsÓ contained in the 416	
model.  Similarly, whilst our ABM contained only three cellular agents (infected and 417	
inflamed KCs and NKT), this abstraction was nevertheless sufficient to probe 418	
previously inaccessible aspects of the underlying biology.   419	
 420	
Our in silico results predicted that chemokine diffusion plays an important role in 421	
regulating the formation of inflammatory foci around infected KCs, though there are 422	
diminishing returns as a result of increased competition when lobules become flooded 423	
with chemokines.  Subsequently, our model predicted an intuitive, but nonetheless 424	
previously unreported mechanism by which the production of NKT cell-attractive 425	
chemokines by inflamed KCs dampens the overall inflammatory response in the liver 426	
microenvironment, reducing the activation received by infected KCs.  Our in silico 427	
data also predicted that this competition could be overcome by increasing the 428	
availability of NKT cells, and we were able to confirm that granuloma frequency can 429	
indeed be increased in vivo by increasing NKT cell numbers using rIL-15. The 430	
relationship between availability of NKT cells and an increase in the frequency of 431	
infected KCs generating granulomas has not previously been demonstrated.  432	
 433	
	 20	
Natural killer T (NKT) cells represent a potent therapeutic target in a variety of 434	
clinical settings, due to their immune adjuvant function and production of various 435	
effector cytokines [54-57]. Protective immunity associated with NKT cell activation 436	
has been reported in several disease settings. For example, Vα14 NKT cells activated 437	
by α-galactosylceramide (α-GalCer) have been shown to inhibit the development of 438	
malaria parasites in mice [58]. Similarly, in a murine model of Mycobacterium 439	
tuberculosis infection, α-GalCer induced activation of NKT cells was associated with 440	
reduced bacterial loads, tissue injury, and improved mouse survival [59].  Conversely, 441	
NKT cells have been implicated as key drivers of liver inflammation such as chronic 442	
liver injury [26].  Although our results suggest that in leishmaniasis the initiation of 443	
granulomatous inflammation can be enhanced by increasing the availability of NKT 444	
cells, further long-term studies would be required to determine whether the host 445	
protective advantages of this intervention outweigh any possible pathological 446	
consequences.  447	
 448	
It is important to recognize that our model has been developed to address early events 449	
in granuloma formation and does not take into account the potential for diversity in 450	
granuloma form and function, including variations in microbicidal activity.  These 451	
may be regulated via other aspects of the immune response that develop over time, 452	
and more complex models have been developed to address some of these issues [60].  453	
Redundancy of immune regulatory pathways is a common finding and it is possible 454	
that other mechanisms come into play at later stages of granuloma evolution that 455	
affects the ability of Kupffer cells to recruit inflammatory cells and initiate granuloma 456	
formation.  The kinetics of chemokine production is also likely to be highly dynamic, 457	
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though in respect of CXCL9 and CXCL10, long term transcriptomic profiling 458	
indicates that expression of these IFNγ-inducible chemokines is sustained for at least 459	
45 days post infection (Ashwin et. al., unpublished).    460	
In summary, our data argue that chemokine production by uninfected trans-activated 461	
KCs provides an example of a novel negative regulatory mechanism to limit the 462	
impact of over-zealous inflammatory responses that might otherwise lead to excess 463	
tissue pathology.  Further studies to evaluate this hypothesis in a broader context of 464	
inflammation are clearly warranted.  465	
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Figure Legends 734	
Figure 1. L. donovani infection induces transactivation of Kupffer cells for 735	
chemokine production  736	
(A) Heat map showing chemokine mRNA abundance in flow sorted Kupffer cells 737	
from nave mice (control) and from KCs isolated from infected mice and separated 738	
into those containing parasites (ÒinfectedÓ) and those that do not contain parasites 739	
(ÒinflamedÓ).  KC isolation was performed at 2h and 12h post infection, with matched 740	
controls.  Lanes numbered 1-4 indicates separate sorts. The gating strategy for 741	
separating ÒinfectedÓ from ÒinflamedÓ KCs is provided in Figure 3 of reference 31. (B 742	
and C) Two modeling scenarios were generated.  In scenario 1 (panel B), only 743	
infected KCs produce sufficient chemokine to attract and retain NKT cells.  In 744	
scenario 2 (panel C) both infected and inflamed KCs produce chemokines to attract 745	
NKT cells, although only infected KCs have the ability to retain these through 746	
cognate interactions.   747	
 748	
Figure 2.  Overview of the liver agent based model 749	
(A)  A simulated sinusoidal network was constructed in quasi-2D space using a 750	
sinusoidal structure generation algorithm (see Supplemental Experimental 751	
Procedures). A drain node representing the portal vein (black) is placed in the centre 752	
of a 2D space with six surrounding entry nodes representing the portal triads (green), 753	
forming an irregular hexagon layout (i). Sinusoids (red) are grown from entry nodes 754	
to the drain node (ii). Additional entry nodes created around original entry nodes 755	
conceptual form a portal triad (iii), allow additional sinusoids to be grown (iv).  756	
Additional sinusoid branches are added between existing sinusoids (v). 757	
Execution of the algorithm is shown in Movie S1.  (B) Node structure of the model 758	
	 35	
underlying KC placement and chemokine diffusion.  Nodes are populated or not with 759	
a single KC, and may attract NKT cells to that node.  Chemokines exert their effect 760	
by ÒdiffusingÓ across nodes.  For further details, see text and Supplementary 761	
Experimental Procedures. (C) Snapshot of 2-photon image of liver from (mT/mG x 762	
lysMcre)F1 mice, showing sinusoids (red) and KCs (green).  763	
 764	
Figure 3.  Response landscapes for parasite-induced KC activation with and 765	
without KC activation in trans.  766	
 767	
(A-D) Two-at-a-time (TAT) parameter analysis showing the effect on total KC 768	
stimulation time (A, C) and on % inflammatory foci (B and D) of modifying either 769	
cumulative time to activate KCs and parasite-induced activation time (A and B)  770	
or cumulative time to activate KCs and bystander activation time (C and D).  For 771	
further details, see Supplementary Experimental Procedures.  772	
 773	
Figure 4. Expansion of NKT Cells promotes granuloma formation 774	
(A) Alternate hypotheses for impact of increasing NKT cell number.  (B) Increasing 775	
NKT cells in silico leads to greater percentages of KCs that form an inflammatory 776	
focus, when qualified at 4, 6 and 8 cells. (C - E) Absolute numbers of NKT (C), NK 777	
(D) and T cells (E) in nave and infected mice with or without administration of rIL-778	
15. Results are pooled from two independent experiments and represent mean±SEM 779	
(n=10 mice per group). *P<0.05, **P<0.01, ***P<0.001, by paired Students t-test. 780	
(F) Percentage of infected KCs with surrounding granuloma in control and rIL-15-781	
treated infected mice. **P<0.01 (n=10 mice).  (G and H)  Heterogeneity of 782	
granulomas comparing infected (G) and rIL-15-treated (H) mice infected with 783	
	 36	
TdTomato-L. donovani (red). Sections were stained using F4/80 (green) and 784	
counterstained with DAPI (blue). 785	
 786	
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Supplemental Figures
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Figure S1. Related to Figure 2. Generation of Nodes and Edges of a Sinusoid Network.
(A-D) See Algorithm 1 in Supplemental Experimental Procedures. (E) Effect on percentage inflammatory foci qualified at 4, 6
and 8 cells, when modifying maximum chemokine diffusion distance.
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Figure S2. Related to Figure 2. State-diagrams for Kupffer cell and NKT cell behaviors.
(A) Infected Kupffer Cell; (B) uninfected Kupffer Cell; (C) NKT cell. See State Transition Diagrams in Supplemental Experi-
mental Procedures.
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Figure S3. Related to Figure 4. IL-15 Promotes NKT Cell Expansion.
(A) Absolute cell numbers for NKT, (B) NK and (C) T cells, and (D) CD1d tetramer+ NKT cells for naı¨ve, IL-15 treated naı¨ve
(IL-15), infected (INF) and IL-15 pre-treated infected (INF+IL-15) mice. (E) Relative frequency of NKT, (F) NK and (G) T cells
for naı¨ve, IL-15 treated naı¨ve (IL-15), infected (INF) and IL-15 pre-treated infected (INF+IL-15) mice. Results are depicted as
mean ± SEM of 5 mice per group. *P0.05, **P0.01 paired Students t-test.
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Figure S4. Related to Figure 2. Aleatory Analysis Determines a Minimum of 300 Simulation Runs per Experiment.
A-test (Vargha and Delaney, 2000) scores for three simulation output measures across sample sizes of (A) 10, (B) 50, (C) 100,
(D) 300 and (E) 500, illustrating that greater than 300 simulation runs are needed to capture the variation in output results and
mitigate uncertainty, summarized in (F).
Supplemental Tables
Biological Parameters Value Source
NKT cell velocity in the sinusoids 10-20µm/minute (Geissmann et al., 2005)
NKT cell numbers in a section of mouse liver lobule ⇠49(⇠1:3 ratio with KCs) Derived from (Lee et al., 2010)
and unpublished data
Kupffer cell numbers per gram 14-20 x 10 6/g (Bouwens et al., 1986)
Infected KCs at 2 hours ⇠23% Unpublished data
KCs per lobule section ⇠146 Unpublished data
Non-branched segment length 43.1 ± 2.25 µm (Ho¨hme et al., 2010)
Mean branching angles of sinusoids 32.5◦ ± 11.2◦ (Ho¨hme et al., 2010)
KC spatial distribution
Percentages:
Periportal (PP) - 43
Midzonal (MZ) - 28
Centrilobular (CV) - 29
Ratios: 4(PP), 3(MZ), 2(CV)
(Bouwens et al., 1986;
Sleyster and Knook, 1982)
Table S1. Related to Figure 2. Table of biological parameters used for calibration.
Domain Platform Justification
KC A1 Infected KCs are infected at initiation of the sim-
ulation, t(0).
KCs rapidly phagocytose
parasites. We are not in-
vestigating conditions pre-
infection.
KC A2 Infected KCs can recruit and retain cells. Unpublished data.
KC A3 Uninfected KCs can only recruit cells. Unpublished data.
KC A4 KCs are immobile KCs have no movement rules (Lee et al., 2010)
KC A5 KC retention of NKT cells
is probabilistic, mediated by
SIRP-a - CD47 interactions
and local IFN-g concentra-
tion.
Cognate interactions occur when two cells are
co-located on the same node and are not mod-
eled explicitly. Retention is modeled probabilis-
tically using a function modified by local IFN-g
level
(Beattie et al., 2010; Svens-
son et al., 2005)
KC A6 NKT produced IFN-g affects
KC attractive chemokine
production.
Retentive chemokine level increases in-line with
local IFN-g level and increases the diffusion dis-
tance of attractive chemokine linearly. Retentive
chemokine diffusion distance can decay.
Simplification, no experi-
mental data available.
KC A7 There is a threshold level of
stimulation required to acti-
vate a KC.
KCs will not transition to an engaged state until
a threshold level of IFN-g is reached.
To facilitate implementation,
no experimental data avail-
able.
NKT A1 NKT cells respond to
chemo- attractant
NKT cells under chemotaxis, when presented
with two or more attraction gradients, will
choose a direction based on attractive chemokine
strength.
To facilitate implementation,
no experimental data avail-
able.
NKT A2 NKT cells interact with KCs NKT cells will interact with the first infected KC
they encounter whilst in chemotaxis.
To facilitate implementation,
no experimental data avail-
able.
NKT A3 The NKT cell population of the lobule section
remains constant; cells exiting the environment
will enter as new cells via an entry point.
NKT A4 NKT cells are capable of be-
coming anergic
NKT cells are refractive to stimulation and take
a period of time to recover after stimulating and
leaving a KC.
(Iyoda et al., 2010)
NKT A5 NKT cells will respond immediately to a
chemokine signal.
To facilitate implementation,
no experimental data avail-
able.
NKT A6 NKT cells can walk the si-
nusoids and switch direction
probabilistically NKT cells
perform a random walk of
the tree- node structure, and
a probability governs their
NKT cells perform a random walk of the tree-
node structure, and a probability governs their
ability to turn in the sinusoids at random.
(Geissmann et al., 2005)
C A1 Attractive chemokines flow
in the same direction as
blood would.
Attraction diffuses downstream of infected KCs
towards the central vein.
Chemotaxis in 3D environ-
ments is poorly understood
(Haessler et al., 2011)
C A2 Strength of attractive chemokine is a function of
distance from source, calculated using a simpli-
fied Ficks Law of diffusion.
To facilitate implementation.
C A3 Chemokine growth is calculated using a sigmoid
function.
To facilitate implementation,
no experimental data avail-
able.
Table S2. Related to Figure 2. Modelling Assumptions. Statement of assumptions made regarding the underlying biological
domain (domain) and how we have abstracted this information in the engineered simulation (platform). Assumptions labeled
KC relate to Kupffer Cells, NKT to NKT Cells, and C to chemokines. Assumptions make it possible to model when data is
limited or there is a gap in understanding or the literature.
Value Units Description Source
p_numInfectedKCs 33 cells
Number of infected kupffer cells in a π*(284μm)^2 
sectional area of sinusoid.
p_numUninfected 113 cells
Number of uninfected kupffer cells in a π*(284μm)^2 
sectional area of sinusoid.
p_numNKTs 49 cells
Number of NKT cells in a π*(284μm)^2 sectional area of 
sinusoid.
Calibrated to unpublished data 
and (Lee et al., 
2010),(Geissmann et al., 
2005)
p_chemoAttract 43200 iterations
Stimulation time required to reach maximum attractive 
chemokine concentration.
p_chemoRetain 172800 iterations
Interaction time required to reach maximum retentive 
chemokine concentration.
p_chemoIFN 172800 iterations Interaction time required to reach activate infected KCs.
Chemokine
No biological equivalent; 
explored and chosen through 
parameter sensitivity analysis
Parameter
Simulation
Calibrated to unpublished data
Value Units Description Source
p_turnProb 0.005 probability
Probability that an NKT cell will reverse direction in the 
sinusoids.
No biological equivalent; 
explored and chosen through 
parameter sensitivity analysis.
p_moveMin 3
p_moveMax 6
p_anergicItns 3600 iterations
Time in iterations for an NKT cell to remain unable to 
stimulate a KC.
p_escapeItns 600 iterations
Time in iterations for an NKT cell to escape the influence of 
KC produced chemo-attractant.
p_leaveProb 0.000265306 probability
The probability of an interacting NKT cell leaving the location 
of an infected KC.
p_minLeaveProb 0.00005 probability
To guard against the probabilistic tipping point whereby 
retention causes cells to never leave.
p_chemoIFN 172800 iterations
Interaction time required to reach maximum attractive 
chemokine concentration.
p_chemoDist 20 distance(nodes) Starting diffusion distance for attractive chemokine.
No biological equivalent; 
explored and chosen through 
parameter sensitivity analysis.
p_ratioCV 0.1 percentage Ratio of infected cells in the CV region of the lobule section
p_ratioMZ 0.25 percentage Ratio of infected cells in the MZ region of the lobule section
p_ratioPP 0.65 percentage Ratio of infected cells in the PP region of the lobule section
p_maxDist 200 distance(nodes) Maximum diffusion distance for attractive chemokine.
Calibrated to twice reported 
max(Weber et al., 2013)
p_ifnThreshold 0.999 threshold
Threshold value of IFN-γ required to activate a KC. 
Chemokine function f(x)→1, therefore a threshold is required.
No biological equivalent
Kupffer cell
Parameter
NKT cell
iterations Value given to link simulation iterations to NKT cell velocity.
Calibrated to published NKT cell 
speeds from (Geissmann et al., 
2005)
No biological equivalent; 
explored and chosen through 
parameter sensitivity analysis.
Bouwens et al., 1986. Sleyster et 
al., 1982.
Table S3. Related to Figure 2. Simulation Parameters. Summary of the simulation parameters, descriptions of their purpose,
values and any data sources for parameters relating to cell numbers and chemokine functions. All estimated values are based on
a comprehensive sensitivity analysis for parameters that have unknown or no clear biological value.
Supplemental Movies
Movie S1. Related to Figure2. Sinusoid structure generation algorithm. Execution of the sinusoid structure generation
algorithm at 8x speed. Drain node (cyan), entry nodes (green) and sinusoids (red).
Supplemental Experimental Procedures
We assume that our sinusoid network exists in a quasi-2D space (we can consider this as a slice through a 3D lobule). We also
assume that the lobule structure is roughly hexagonal with a single central vein in the centre and six portal triad areas placed at
roughly regular intervals around the central vein. The flow of blood borne cells is assumed to be from portal triads to the central
vein, so in the algorithmic description below the central vein is termed a drain node, and the portal triad regions deemed entry
nodes.
Algorithm 1 describes how the nodes and edges of the sinusoid network are generated, whilst Algorithm 2 describes how the
overall sinusoid network (the lobule) is generated using Algorithm 1. Ho¨hme et al. (2010) provide us with the following statistics
that guide Algorithm 2:
• Average length between central vein and portal triad = 284µm;
• Average length of a non-branched sinusoid = 43.1µm;
• Average angle between branching sinusoids = 32.5◦.
Algorithm 1: Sinusoid branch generation
1. A potential new node (µ) is generated 1µm from the current node (δ )
(a) If we are within range of an attracting node (α) then µ is generated in the direction of α (see Figure S4(B)).
(b) Otherwise µ is generated based on our current direction with a small random adjustment (see Figure S4(A)).
2. Create a new edge between δ and another node:
(a) If the line between δ and µ intersects another edge in the sinusoid network, then connect δ to the closest existing
node (see Figure S4(D)).
(b) Otherwise connect δ and µ (see Figure S4(C)).
3. Repeat Steps 1 and 2 until an intersection is detected.
Algorithm 2: Sinusoid network (lobule) generation
1. A drain node (representing the central vein) is placed in the centre of the 2D space, surrounded by six entry nodes (repre-
senting the locations of portal triads) in an irregular hexagon formation (see Figure 2(Ai)). The exact location of the entry
nodes is determined stochastically.
2. For each of the six entry nodes a sinusoid branch is grown (see algorithm 1) from the entry node towards the attracting
drain node (see Figure 2(Aii)).
3. An additional set of entry nodes is created for each original entry node and aligned with the original node. These additional
nodes represent additional sources of blood supply coming out of the portal triad (see Figure 2(Aiii)).
4. For each of the new entry nodes a sinusoid branch is grown (see algorithm 1) from the entry node towards the existing
sinusoid structure (see Figure 2(Aiv)).
5. Additional sinusoids are created to connect existing sinusoids (see Figure 2(Av)).
• Select the longest sinusoid in the structure
• Select a node in the longest sinusoid and grow a sinusoid (see algorithm 1) to either the left or right at an angle drawn
from a normal distribution with a mean of 32.5◦.
• Repeat until the mean sinusoid length of the entire structure reaches 43.1µm.
Cell Attraction Dynamics
If we assume an infected KC diffuses chemokine to a downstream node α , chemokine strength at α is a function of distance:
λ /δ
Where:
λ is the chemokine strength at the infected node.
δ is the distance in nodes between the KC and α .
Uninfected KCs are unable to modify their attraction diffusion distance from the parameterized minimum (Scenario A only),
whereas infected-KC attractive chemokine diffusion distance is variable between a minimum and maximum distance. That
distance is calculated as a function of the current level of attractive chemokine at the source KC location:
δ = | λ · (δmax - δmin) |
Where:
λ is the chemokine strength at the infected node.
δmax is the maximum parameterized diffusion distance.
δmin is the minimum parameterized diffusion distance
The function is floored to the nearest integer and that is used as the updated diffusion distance.
Cell Retention Dynamics
The equation governing NKT cell retention is:
δnktleave = δ leave (φ · δ leave)
Where:
δnktleave is the probability of an NKT cell leaving an infection site.
δ leave is the maximum parameterized retention probability.
φ is the level of retentive chemokine at the infected node.
As the calculated probability will approach zero given suitable conditions, a minimum retention probability is parameterized to
ensure that KCs do not become so retentive that NKT cells are then incapable of leaving.
State-Transition Diagrams
Figure S2 depicts state-transition diagrams using the Unified Modelling Language (UML). These diagrams are the engineering
specific (platform) ones used to create the simulator. To improve clarity, various annotations are added to convey information
relevant to our modelling context. Arrows denote transitions between states. Square brackets ([]) denote guards for a transition,
conditions that must be met before a transition can occur. Dashed lines denote states or behaviours that occur concurrently.
Where an assumption number is stated on a diagram, denoted by (An), refer to the relevant cell assumption table. The δ ()
notation denotes an interaction that might occur probabilistically, for example a cell-cell interaction.
• Infected Kupffer Cells (Figure S2(A)): begin in an aware state and have a minimum level of attractive chemokine and
minimum diffusion distance of attraction. If the level of cell-local interferon-gamma produced by NKT cells reaches a
threshold (ifnThreshold), infected KCs become engaged. When infected KCs are engaged, if there is sustained interaction
with NKTs, indicated by δ (NKT), they will increase their level of attraction and retention.
• Uninfected Kupffer Cells (Figure S2(B)): always in an aware state and only diffuse the minimum level of attractive
chemokine. They do not interact with NKTs by any other means.
• NKT cells (Figure S2(C)): have two state types, ActionStates and MoveStates. The initial ActionState is inactive. If
an infected KC is encountered the NKT will begin producing interferon- until probabilistically leaving mediated by the
retention level of the KC. If NKT cells encounter uninfected KCs, they will transition to the recovering state. NKTs
leave the recovering state after a time sampled from a normal distribution, this time is significantly shorter for NKTs
that previously left uninfected KCs, and hence havent been in the producing state. The default NKT cell MoveState is
patrolling. Upon sensing a level of attraction, NKT cells will transition to a chemotaxing state. Interaction with an infected
KC will cause the NKT to switch to an aggregating state; alternatively an uninfected KC encounter will lead back to
a patrolling state. Aggregating NKT cells can transition to patrolling behavior probabilistically. Should NKT cells exit
the liver environment, if the entry condition is satisfied, they will emerge from an environment entry point, effectively as
another cell.
Parameterizing and Calibrating the Simulation
A full summary of the biological data available that was used to calibrate the simulation is listed in Table S1, though these are
merely the domain specific parameters, and a number of implementation specific parameters are required in order to abstract
domain behaviors into executable computer code. A good example of an implementation specific parameter relates to NKT cell
speed. NKT cells traverse the sinusoids at 10-20m/minute. In the simulation, this corresponds to 10-20 nodes/minute. Our
simulation iterations are in seconds, so for a cell to travel at a maximum speed of 20 nodes/minute it would have to move every 3
simulation iterations (p moveMin), and a minimum speed of 10 nodes/minute every 6 simulation iterations (p moveMax). Rather
than have individual cell speed remain constant, we allow it to be dynamic within the published biological range. We calculate,
probabilistically between p moveMin and p moveMax, the number of iterations a cell will remain stationary before its next move.
This allows individual cells to speed up and slow down dynamically, yet maintains a normal distribution of cell speeds across
the population and within the biologically specified range. The entire list of baseline simulation parameters can be viewed in
Table S3. Several parameters have no biological equivalent though are fundamental for the implementation of many behaviors.
We performed parameter sensitivity analysis (SA) in order to determine which parameters the simulation is extremely sensitive
to, and to establish baseline parameter values. Finally SA allows us to ensure we are always interpreting our results with the
knowledge that particular extreme parameter combinations might influence those results.
Each simulated experiment is run across 10 separate structures in order to approximate variance across the set. For each
parameter value investigated (or combination of parameter values) per experiment, 500 simulation runs are performed, this
number chosen after performing aleatory uncertainty analysis on the simulator. Aleatory analysis can be used to determine the
minimum number of replicates runs required to both mitigate the effects of stochasticity on simulation output, and to generate
results that cover a representative spectrum of possible system behaviours (Alden et al., 2013). Fig. S3f shows that 300 simulation
runs per parameter combination are sufficient to have acceptable uncertainty (small variance between identical sample sizes),
though we perform 500 in order to strike a balance between further reducing A-test effect size (Vargha and Delaney, 2000) and
maintaining tractable simulated-experiment execution times.
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